IMAX shareholder plans $436K stock sale in 2026
IMAX CORP (IMAX) is the issuer for a planned resale of its common stock under Rule 144 by Kenneth Weissman.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IMAX CORP (IMAX) is the issuer for a planned resale of its common stock under Rule 144 by Kenneth Weissman. The notice covers a proposed sale of 8,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $436,293.60 and a proposed sale date of August 25, 2026 on the NYSE.
The 8,000 shares were acquired on March 7, 2025 as restricted stock vesting under a registered plan, from IMAX as issuer, with cash as the form of payment. This filing is a procedural notice of intent to sell and does not itself change IMAX’s capital structure or operations.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock financial
registered plan financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing involving IMAX (IMAX) disclose?
Does this Form 144 filing by Kenneth Weissman directly affect IMAX (IMAX) cash flows?
AI-generated analysis. How Rhea-AI works. Not financial advice.